Analysts have been eager to weigh in on the Healthcare sector with new ratings on Virbac SA (GB:0NM7 – Research Report), Nicox SA (GB:0RCQ – Research Report) and Biophytis SA (DE:6XB – Research Report).
Virbac SA (GB:0NM7)
Kepler Capital analyst Arsene Guekam maintained a Hold rating on Virbac SA on July 19 and set a price target of EUR260.00. The company’s shares closed yesterday at EUR265.85.
According to TipRanks.com, Guekam is ranked #7986 out of 8528 analysts.
Virbac SA has an analyst consensus of Hold, with a price target consensus of EUR260.00.
See Insiders’ Hot Stocks on TipRanks >>
Nicox SA (GB:0RCQ)
Kepler Capital analyst Clémence Thiers maintained a Buy rating on Nicox SA on July 19 and set a price target of EUR2.70. The company’s shares closed yesterday at EUR0.45.
According to TipRanks.com, Thiers is ranked #8184 out of 8528 analysts.
Currently, the analyst consensus on Nicox SA is a Moderate Buy with an average price target of EUR2.70.
Biophytis SA (DE:6XB)
In a report issued on July 19, Nicolas Pauillac from Kepler Capital maintained a Hold rating on Biophytis SA, with a price target of EUR0.02. The company’s shares closed yesterday at EUR0.02.
According to TipRanks.com, Pauillac is ranked #3932 out of 8528 analysts.
Biophytis SA has an analyst consensus of Hold, with a price target consensus of EUR0.02.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
